Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy.

Xiong Z, Ampudia Mesias E, Pluhar GE, Rathe SK, Largaespada DA, Sham YY, Moertel CL, Olin MR.

Clin Cancer Res. 2020 Jan 1;26(1):232-241. doi: 10.1158/1078-0432.CCR-19-2234. Epub 2019 Oct 17.

2.

Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma.

Olin MR, Ampudia-Mesias E, Pennell CA, Sarver A, Chen CC, Moertel CL, Hunt MA, Pluhar GE.

Cancers (Basel). 2019 Jan 24;11(2). pii: E137. doi: 10.3390/cancers11020137.

3.

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

Xiong Z, Ampudia-Mesias E, Shaver R, Horbinski CM, Moertel CL, Olin MR.

Immunotherapy. 2016 Sep;8(9):1059-71. doi: 10.2217/imt-2016-0033.

Supplemental Content

Loading ...
Support Center